Cambridge Antibody Technology
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:AstraZeneca
|
| gptkbp:acquisitionYear |
2006
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focus |
antibody therapeutics
|
| gptkbp:foundedIn |
1989
|
| gptkbp:founder |
gptkb:David_Chiswell
gptkb:Sir_Greg_Winter |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cambridge Antibody Technology
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:mergedInto |
gptkb:MedImmune
|
| gptkbp:notableEmployee |
gptkb:Sir_Greg_Winter
|
| gptkbp:notableProduct |
gptkb:Humira
|
| gptkbp:parentCompany |
gptkb:AstraZeneca
|
| gptkbp:researchArea |
phage display technology
|
| gptkbp:stockExchange |
gptkb:London_Stock_Exchange
|
| gptkbp:stockSymbol |
CAT
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
www.cambridgeantibody.com
|
| gptkbp:bfsParent |
gptkb:Sir_Greg_Winter
|
| gptkbp:bfsLayer |
5
|